Clearside Biomedical, Inc. — Form D

Clearside Biomedical, Inc. of ALPHARETTA, 2Q, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-13. The offering totals $320K, of which $320K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Gerald D Cagle, Ph.D.DirectorAlpharetta, GA
Christy L Shaffer, Ph.D.DirectorAlpharetta, GA
Daniel H WhiteDirectorAlpharetta, GA
Derek D YoonDirectorAlpharetta, GA
Evgeny D ZaytsevDirectorAlpharetta, GA
Charles D DeignanExecutive OfficerAlpharetta, GA
Glenn D NoronhaExecutive OfficerAlpharetta, GA
Daniel H WhiteExecutive OfficerAlpharetta, GA
Daniel WhiteDirectorSouthfield, MI
Daniel WhiteExecutive OfficerSouthfield, MI
Daniel WhitePromoterSouthfield, MI
William D HumphriesDirectorHorsham, PA
Christy H ShafferDirectorChapel Hill, NC
Christy H ShafferPromoterChapel Hill, NC
George LasezkayDirectorAlpharetta, GA
George LasezkayExecutive OfficerAlpharetta, GA
Charles A DeignanExecutive OfficerAlpharetta, GA
Jeffrey L EdwardsDirectorAlpharetta, GA
Christy L ShafferDirectorAlpharetta, GA
Richard D CroarkinDirectorAlpharetta, GA
William A HumphriesDirectorWayne, PA
Daniel H WhitePromoterAlpharetta, GA
Charlie D DeignanExecutive OfficerAlpharetta, GA
Clay D ThorpDirectorDurham, NC
Christy D ShafferDirectorDurham, NC

Other filings by this issuer (7)

FiledFormOfferingSold
2019-12-04D$3.3M$3.3M
2015-12-08D$20.0M$14.4M
2014-09-15D$20.0M$16.2M
2014-05-12D$6.0M$3.0M
2013-02-12D$8.5M$7.9M
2012-02-16D/A$4.0M$3.2M
2012-01-09D$4.0M$1.2M

More